| |
|
|
|
|
|
|
|||
|
Blood, 1 March 2008, Vol. 111, No. 5, pp. 2929-2940. Prepublished online as a Blood First Edition Paper on January 4, 2008; DOI 10.1182/blood-2007-06-096602.
Submitted June 19, 2007
Department of Medicine and Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY, United States * Corresponding author; email: vandenbm{at}mskcc.org.
Dendritic cells (DCs) are considered critical for the induction of graft-versus-host disease (GvHD) after bone marrow transplantation (BMT). In addition to their priming function, dendritic cells have been shown to induce organ-tropism through induction of specific homing molecules on T cells. Using adoptive transfer of CFSE-labeled cells we first demonstrated that alloreactive T cells differentially upregulate specific homing molecules in vivo. Host-type dendritic cells from the GvHD target organs liver and spleen or skin- and gut-draining lymph nodes effectively primed naive allogeneic T cells in vitro with the exception of liver-derived dendritic cells, which showed less stimulatory capacity. Gut-derived dendritic cells induced alloreactive donor T cells with a gut-homing phenotype which caused increased GvHD mortality and morbidity compared to T cells stimulated with dendritic cells from spleen, liver and peripheral lymph nodes in an MHC-mismatched murine BMT model. However, in vivo analysis demonstrated that the in vitro imprinting of homing molecules on alloreactive T cells was only transient. In conclusion, organ-derived dendritic cells can efficiently induce specific homing molecules on alloreactive T cells. A gut-homing phenotype correlates with increased GvHD mortality and morbidity after murine BMT underlining the importance of the gut in the pathophysiology of GvHD.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||